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Abstract
Introduction The response to dietary challenges has been proposed as a more accurate measure of metabolic health than 
static measurements performed in the fasted state. This has prompted many groups to explore the potential of dietary chal-
lenge tests for assessment of diet and lifestyle induced shifts in metabolic phenotype.
Objectives We examined whether the response to a mixed-meal challenge could provide a readout for a weight loss (WL)-
induced phenotype shift in abdominally obese male subjects. The underlying assumption of a mixed meal challenge is that 
it triggers all aspects of phenotypic flexibility and provokes a more prolonged insulin response, possibly allowing for better 
differentiation between individuals.
Methods Abdominally obese men (n = 29, BMI = 30.3 ± 2.4 kg/m2) received a mixed-meal challenge prior to and after an 
8-week WL or no-WL control intervention. Lean subjects (n = 15, BMI = 23.0 ± 2.0 kg/m2) only received the mixed meal 
challenge at baseline to have a benchmark for WL-induced phenotype shifts.
Results Levels of several plasma metabolites were significantly different between lean and abdominally obese at baseline as 
well as during postprandial metabolic responses. Genes related to oxidative phosphorylation in peripheral blood mononu-
clear cells (PBMCs) were expressed at higher levels in abdominally obese subjects as compared to lean subjects at fasting, 
which was partially reverted after WL. The impact of WL on the postprandial response was modest, both at the metabolic 
and gene expression level in PBMCs.
Conclusion We conclude that mixed-meal challenges are not necessarily superior to measurements in the fasted state to 
assess metabolic health. Furthermore, the mechanisms accounting for the observed differences between lean and abdominally 
obese in the fasted state are different from those underlying the dissimilarity observed during the postprandial response.
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1 Introduction
Healthy individuals are able to respond to external stimuli 
by keeping biological parameters within narrow homeo-
static bandwidths. As a consequence, current approaches 
focusing on disease risk biomarkers mostly lack the sen-
sitivity to detect the effects of lifestyle and dietary inter-
ventions aimed at improving or sustaining health. Hence, 
there is a growing awareness that ‘health’ should not just 
be defined as ‘the absence of disease’, but is more accu-
rately described as ‘resilience of homeostatic control’, 
i.e., the ability to cope with daily challenges (Huber et al. 
2011) without drifting out of the regulated homeostatic/
allostatic zone (Ommen et al. 2009). The concept of the 
human body as an orchestrated machine that continuously 
adapts to a changing environment has been embraced by 
the nutritional field and coined as ‘phenotypic flexibility’ 
(Ommen et al. 2014). The earlier introduced concept of 
‘metabolic flexibility’ departs from a narrower definition 
of phenotypic flexibility and specifically refers to the abil-
ity of organs to change fuel use depending on availability 
(Corpeleijn et al. 2009). The capacity to switch from car-
bohydrate to fat oxidation and vice versa depending on 
their supply and demand is crucial for optimal metabolic 
homeostasis, and thus an important aspect of phenotypic 
flexibility. In both concepts, the resilience capacity can be 
tested by the assessment of the stress response to short-
term perturbations.
Specific dietary challenge tests have been described, 
each probing the resilience of different metabolic regu-
latory processes (Ommen et al. 2009). The best known 
challenge test is the oral glucose tolerance test (OGTT), 
which specifically probes the resilience of glucose metabo-
lism (Ho et al. 2013). The oral lipid and protein tolerance 
tests (OLTT and OPTT, respectively) probe the resilience 
of other, and partially overlapping metabolic regulatory 
processes (Stroeve et al. 2015; Krug et al. 2012; Wopereis 
et al. 2013). The use of a mixed-meal challenge, compris-
ing protein, glucose and lipids, has been proposed to target 
multiple organs and more broadly encompass phenotypic 
flexibility (Stroeve et al. 2015; Wopereis et al. 2017). By 
challenging metabolic regulatory processes by means of 
a dietary challenge, dynamic changes in nutrient metabo-
lism might be uncovered, allowing better exploration of 
the individual capacity to cope with metabolic stressors 
(Krug et al. 2012; Broek et al. 2017).
Next to metabolite profiling, which has already been 
shown to be useful in revealing the complex changes upon 
dietary challenges (Ommen et  al. 2014; Stroeve et  al. 
2015), gene expression of peripheral blood mononuclear 
cells (PBMCs) has been proposed as a readout of biologi-
cal processes such as inflammation, metabolism (Afman 
et al. 2014), oxidative stress and inflammatory status (Cru-
jeiras et al. 2008; Sheu et al. 2008). PBMCs can be easily 
collected in adequate quantities for transcriptomics stud-
ies, and it has been shown that nutritional components can 
modulate pro- and anti-inflammatory mechanisms (Afman 
et al. 2014; Esser et al. 2015). A previous study indicated 
that long-term consumption of a Mediterranean diet (high 
content of unsaturated fats and polyphenols) reduces met-
abolic stress and oxidative phosphorylation activity in 
PBMCs obtained from overweight men and women (Dijk 
et al. 2012). Furthermore, it has also been shown that diet-
induced weight loss (WL) modulates immune-inflamma-
tory and antioxidant responses and mRNA expression in 
PBMCs (Mello et al. 2012).
We examined whether a mixed-meal challenge response 
could provide a sensitive readout for a shift in phenotypical 
flexibility upon WL in abdominally obese male subjects. By 
combining metabolite profiling in plasma and whole genome 
gene expression in PBMCs, we aimed at comprehensively 
describing the changes in the metabolome and gene expres-
sion underlying phenotypic flexibility. We were in particu-
lar interested whether the effect of WL on the postprandial 
response would provide a more sensitive readout than the 
observation in the fasting state. In order to have a benchmark 
for this comparison, we first compared fasting baseline and 
postprandial response between lean and abdominally obese 
subjects. Subsequently, we assessed the effect of dietary WL 
accompanied by improvements in vascular function, lipid 
profile, and insulin sensitivity on the fasting baseline and 
postprandial response in abdominally obese men.
2  Materials and methods
2.1  Subject characteristics
Fifteen lean men with a waist circumference below 94 cm 
(BMI = 23.0 ± 2.0 kg/m2) and 29 abdominally obese men 
with a waist circumference between 102 and 110 cm par-
ticipated in the study (BMI = 30.3 ± 2.4 kg/m2). Baseline 
characteristics of subjects of which microarrays and metab-
olomics were performed are displayed in Table 1. All vol-
unteers were apparently healthy and did not receive proton 
pump inhibitors, anti-hypertensive medication or drugs 
known to affect lipid or glucose metabolism. All participants 
gave written, informed consent before entering the study. 
The study was approved by the Medical Ethics Committee 
of Maastricht University Medical Center and registered at 
clinicaltrials.gov as NCT01675401 (Joris et al. 2016).
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2.2  Study design
Full details of the study have been published before (Joris 
et al. 2016). In brief, abdominally obese men received a 
mixed-meal challenge prior to and after an 8-week WL or 
no-WL control intervention. Lean subjects were included as 
a reference group and only received the mixed meal chal-
lenge at baseline (Fig. 1). Power calculations were based 
on an α of 0.05, and a within-subject and between-subject 
variability of 2.82 percentage points in the primary outcome 
variable FMD (Joris et al. 2016). Prior to the intervention 
(D1), all subjects underwent a mixed-meal challenge. The 
standardized mixed meal consisted of two muffins and 
300 mL 0% fat milk, which provided 4.6 MJ (4598 kJ or 
1100 kcal): 56.6 g fat, 26.5 g protein and 121 g carbohy-
drate. Blood samples were collected at fasting and imme-
diately after ingestion of the challenge over 4 h at regular 
intervals (0, 30, 60, 120, 180, 240 min). Subjects assigned to 
diet-induced WL (Fig. 1) program consumed a commercially 
available very low energy diet (Modifast; Nutrition et Santé, 
Benelux, Breda, The Netherlands) for 4–5 weeks providing 
2.1 MJ/day. Once the waist circumference was below 102 cm 
(the NCEP ATP II cut-off value) within this period, subjects 
consumed a mixed-solid energy-restricted diet up to 4.2 MJ/
day with a recommended composition for the following 
1–2 weeks. Then, subjects consumed a diet matching their 
energy requirements to maintain their newly achieved body 
weights (weight-stable conditions) for at least 2 weeks. Sub-
jects underwent the same mixed-meal challenge again after 
the WL intervention (D2). Blood samples were collected 
at the same time intervals as on D1. Subjects assigned to 
the control (CTRL, Fig. 1) intervention underwent the same 
tests, but maintained their habitual diet, physical activity 
levels and alcohol consumption during 8 weeks. The period 
between the first and second measurements was the same 
for the WL intervention and control (CTRL) groups. More 
details on the composition of low energy diet and mixed 
meal challenge can be found elsewhere (Joris et al. 2016).
2.3  Sample collection
On the day before blood sampling, subjects were asked not 
to perform any strenuous physical exercise or to consume 
alcohol. On the morning of blood sampling—after a 12 h 
Table 1  Characteristics of lean 
subjects and abdominally obese 
subjects before and after weight 
loss or control interventions
Data are presented as mean ± SD
WL weight loss intervention, CTRL control group, D1, D2 days  before and after intervention (see also 
Fig. 1), BMI body mass index, LBM lean body mass
*A significant effect of weight loss (P < 0.05)
Lean WL(D1) WL(D2) CTRL(D1) CTRL(D2)
Number 15 14 14 15 15
Age (years) 47.4 ± 17 44 ± 15 44.8 ± 14.0
Weight (kg) 73.0 ± 7.5 96.6 ± 8.6 87.3 ± 8.6* 98.9 ± 9.9 98.1 ± 9.5
Height (m) 1.77 ± 0.07 1.79 ± 0.05 1.80 ± 0.07
BMI (kg/m2) 23.0 ± 2.0 30.0 ± 1.8 26.9 ± 1.6* 30.7 ± 2.9 30.4 ± 2.8
Waist circumference (cm) 85.4 ± 6.7 106.8 ± 3.6 95.7 ± 4.5* 106.8 ± 3.9 106.2 ± 3.8
Hip circumference (cm) 95.9 ± 4.1 108.4 ± 4.9 102.7 ± 4.5* 109.5 ± 7.0 109.3 ± 7.8
LBM (kg) 54.2 ± 6.7 67.1 ± 6.9 61.5 ± 8.9 69.2 ± 10.4 69.8 ± 10.7
Fat mass (%) 19.0 ± 6.5 29.5 ± 4.4 25.8 ± 5.0 29.8 ± 4.3 28.3 ± 4.1
Glucose (mmol/L) 5.1 ± 2.9 5.3 ± 0.47 5.0 ± 0.33 5.3 ± 0.48 5.3 ± 0.37
Insulin (µU/mL) 7.0 ± 1.7 12.5 ± 5.5 7.8 ± 3.4* 12.0 ± 6.5 12.1 ± 5.2
Fig. 1  Schematic overview 
of the study design. D1, D2 
before and after intervention, 
respectively, WL weight loss 
intervention group, CTRL con-
trol group. The arrows indicate 
the phenotype comparisons 
made in this study (lean vs. 
abdominally obese, before and 
after interventions)
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overnight fast (from 8 p.m.) subjects were only allowed to 
drink a glass of water in the morning. Subjects were also 
asked not to consume high-fat foods on the day prior to the 
test days and to come to the test centre by public transport 
or car to standardize measurements as much as possible.
An intravenous cannula was inserted, and blood samples 
were taken at fasting and after mixed meal consumption both 
before and after the WL intervention at six time points [fast-
ing (T0) and 30, 60,120,180 and 240 min in the postprandial 
state]. Metabolic profiling was performed on all time points 
and transcriptomics analysis of PBMCs only at fasting (T0) 
and after 4 h in the postprandial state (T4).
2.4  PBMC and RNA isolation
PBMCs were isolated before and 4 h after mixed meal chal-
lenge by using BD Vacutainer Cell Preparation Tubes. RNA 
was isolated (RNeasy Micro kit, Qiagen, Venlo, The Nether-
lands), quantified (Nanodrop ND 1000, Nanodrop Technolo-
gies, Wilmington, DE, USA) and integrity was checked by 
an Agilent 2100 Bioanalyser with RNA 6000 microchips 
(Agilent Technologies, South Queensferry, UK). Samples 
were included for microarray analysis if RNA integrity num-
ber was > 7.
2.5  Microarray processing
PBMC samples from 15 lean and 29 abdominally obese sub-
jects yielded enough RNA of sufficient quality at all collec-
tion points to perform microarray analysis. Microarray anal-
ysis was performed for each individual at fasting (T0) and 
4 h (T4) in the postprandial state. The 4 h timepoint was cho-
sen for transcriptomics analysis to allow for comparison to 
previous studies (Esser et al. 2015). Total RNA was labelled 
using a one-cycle cDNA labelling kit (MessageAmp™ II-
Biotin Enhanced Kit; Ambion, Inc., Nieuwerkerk a/d IJs-
sel, Netherlands) and hybridized to GeneChip® Human 
Gene 1.1 ST Array targeting 19 738 unique gene identifiers 
(Affymetrix, Inc., Santa Clara, CA, USA). Sample labelling, 
hybridization to chips, and image scanning were performed 
according to the manufacturers’ instructions.
2.6  Microarray analysis
Microarray signals were normalized using the robust mul-
tichip average algorithm. Data was filtered using universal 
expression codes filtering with a 50% cut-off, correspond-
ing to a 50% likelihood that a gene is expressed (Piccolo 
et al. 2012). Significant differences of individual genes 
were tested using the limma R library (Smyth 2005). At 
fasting, the expression of genes between groups was defined 
as different when P was < 0.05 in an unpaired t-test with 
empirical Bayes correction. Gene expression was defined as 
postprandial changed between T0 and T4 h when P < 0.05 
in a paired t-test with empirical Bayesian correction. Data 
were further analysed with gene set enrichment analy-
sis (GSEA) using pre-ranked lists based on the t-statistic 
(Subramanian et al. 2005). Gene sets with a false discovery 
rate (FDR Q < 0.2) were defined as significantly regulated. 
Pathway analyses were performed using ingenuity pathway 
analysis (Qiagen, Redwood City, http://www.qiage n.com/
ingen uity) on filtered dataset and filtered genes were used as 
background. Plots were made using the R libraries ggplot2 
and gplots (Wickham 2009; Warnes et al. 2009).
2.7  Plasma metabolic profiling
Amino acids and biogenic amines were derivatized (Acc-
Tag) in 5 µL aliquots of plasma and analyzed using an 
Acquity UPLC system equipped with autosampler (Waters, 
Etten-Leur, The Netherlands) and coupled to a Xevo Tan-
dem quadrupole mass spectrometer (Waters) operated using 
QuanLynx data acquisition software (version 4.1; Waters). 
An Accq-Tag Ultra column (Waters) was used. The Xevo 
TQ was used in the positive-ion electrospray mode and all 
analytes were monitored in multiple reaction monitoring 
(MRM) using nominal mass resolution. Acquired data were 
evaluated using TargetLynx software (Waters), by integra-
tion of assigned MRM peaks and normalization using proper 
internal authentic standards (Noga et al. 2012). For analysis 
of amino acids, their 13C–15N labeled analogs were used 
and for other amines the closest-eluting internal standard 
was employed.
Acylcarnitines, trimethylamine-N-oxide, choline, betaine, 
deoxycarnitine and carnitine were analyzed in 5 µL plasma, 
spiked with an internal authentic standard, using a UPLC–MS/
MS. Also here an Accq-Tag Ultra column was used. The Xevo 
TQ was used in the positive-ion electrospray mode and all ana-
lytes were monitored in MRM using nominal mass resolution. 
In-house developed algorithms (Kloet et al. 2009) were applied 
using the pooled QC samples to compensate for shifts in the 
sensitivity of the mass spectrometer over the batch. Organic 
acids were measured by GC–MS using 50 µL of plasma sam-
ple prepared using a two-step derivatization procedure with 
subsequent oximation using methoxyamine hydrochloride 
(MeOX) and silylation using N-methyl-N-(trimethylsilyl)tri-
fluoroacetamide (MSTFA). Samples were measured on an 
Agilent GC (7890A) coupled to Agilent Quadrupole-MS with 
EI source (Agilent MSD 5975C). Separation was performed 
using a HP-5MS column (30 m × 0.25 m × 0.25 µm; Agi-
lent). The raw data were pre-processed using Agilent Mass-
Hunter Quantitative Analysis software for GC–MS (Agilent, 
Version B.04.00), and quantitation of metabolite response 
was calculated as the peak area ratios of the target analyte 
to the respective internal authentic standard. Oxylipins were 
analyzed as previously described (Strassburg et al. 2012). In 
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short, compound extraction was performed with SPE using a 
hydrophilic–lipophilic balance and samples were analyzed by 
LC using a C18 column coupled to ESI on a triple quadrupole 
mass spectrometer, where oxylipins were detected in negative 
ion mode using dynamic SRM, while chromatographic sepa-
ration was achieved with a C18 column. Peak areas of target 
metabolites were corrected by appropriate internal authentic 
standards and calculated response ratios were used throughout 
the analysis. Quality controls were run every 10 samples and 
before and after calibration samples, amounting to a total of 
62 QC samples per platform. In-house developed algorithms 
were applied using the pooled QC samples to compensate 
for shifts in the sensitivity of the mass spectrometer over 
the batch. Serum metabolite concentrations determined by 
NMR were measured as described by Mihaleva et al. (2014). 
Briefly, high resolution 1H NMR spectra were acquired on 
ultrafiltrated serum samples at 300 K using a Bruker Avance 
III 600 MHz spectrometer. Automated quantum mechanical 
line shape fitting of the 1H NMR spectra was performed using 
PERCH NMR software to obtain absolute concentrations of 
44 metabolites. The median in the RSDs of metabolite con-
centrations in the QC samples measured for all platforms was 
8%. All metabolites reported in this study were identified at 
MSI level 1.
2.8  Metabolomics statistical analysis
We used Spearman rank correlations to correlate plasma 
metabolite concentrations and phenotypical parameters (LBM, 
HOMA). These correlations were also determined for nadir 
and Δ-nadir acylcarnitine values (Ramos-Roman et al. 2012). 
Nadir acylcarnitine values were defined as the lowest value 
achieved during the 4 h after the meal. Δ-Nadir was calculated 
as difference between nadir and T0 values. The postprandial 
response was considered as the incremental area under the 
curve (iAUC) (Carstensen et al. 2003). For the iAUC calcula-
tion, the values at fasting (T0) were subtracted from the total 
AUC. Comparison between abdominally obese and lean group 
was performed using analysis of variance. To evaluate the 
intervention effect on fasting metabolites (T0) and the inter-
vention effect on postprandial response (iAUC) in abdominally 
obese subjects, statistical analysis was performed using linear 
mixed models. A P < 0.05 was considered to be statistically 
significant. Local FDR (lFDR) was used to correct for multiple 
testing (Strimmer 2008; Box et al. 1994). All calculations were 
performed using R (version 3.2.1).
3  Results
3.1  Metabolic differences between lean 
and abdominally obese subjects
In order to have a benchmark for the comparison of 
abdominally obese subjects before and after WL, we first 
considered the difference between lean and abdominally 
obese subjects (Fig.  1). In the fasted state, 19 plasma 
metabolites were significantly different between abdomi-
nally obese subjects and lean subjects (Table 2), includ-
ing branched chain and other amino acids, a fatty acid 
derived acylcarnitine (FAAC), and metabolites related to 
the TCA cycle. For a number of oxylipins we observed 
significantly lower plasma levels in the abdominally obese 
subjects compared to the lean subjects. Upon the mixed 
meal challenge, four types of postprandial metabolic 
responses could be recognized, i.e., metabolite changes 
related to glucose metabolism, amino acid metabolism, 
lipid metabolism and ketogenesis (Shaham et al. 2008). 
Figure 2 presents typical postprandial curves for these 
response types. Both lean and abdominally obese sub-
jects followed similar responses over time. Metabolites 
for which the longitudinal response, expressed as iAUC, 
significantly (P < 0.05) differed between abdominally 
obese and lean subjects are presented in Table 2. The eight 
metabolites that were different between lean and abdomi-
nally obese included a number of amino acids, but not 
branched chain amino acids. Interestingly, 2-hydroxyis-
ovalerate, a catabolite of branched chain amino acids was 
also significantly different.
In the fasted state, 1862 genes were differently 
expressed (P < 0.05) in PBMCs between lean and 
abdominally obese subjects. The mixed meal challenge 
changed the expression of 1305 genes in abdominally 
obese and 1707 genes in lean subjects. The response to 
the meal challenge of 1537 genes differed between lean 
and abdominally obese (Δ abdominally obese T4–T0 vs. 
Δ lean T4–T0). A total of 359 genes were both differ-
entially expressed between abdominally obese and lean 
after fasting and differed between abdominally obese and 
lean subjects in response to the mixed meal challenge 
(Fig. S1). In the fasting samples, GSEA identified gene 
sets that were enriched in abdominally obese compared 
to lean subjects (FDR < 0.2), which mainly belonged to 
oxidative phosphorylation and the electron transport chain. 
Gene sets involved in immune regulation were enriched in 
lean compared to abdominally obese subjects (Supplemen-
tary Table S1). In the postprandial state, genes related to 
immune pathways and glucose metabolism were enriched 
in abdominally obese as compared to lean (Δ abdominally 
obese T4–T0 vs. Δ lean T4–T0, Supplementary Table S2). 
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In total, in the fasting state nine gene sets were positively 
enriched and nine gene sets were negatively enriched in 
abdominally obese compared to lean subjects (FDR < 0.2). 
In the postprandial state, 114 gene sets were upregulated 
in abdominally obese subjects compared to lean subjects, 
while 15 gene sets were downregulated.
3.2  Impact of weight loss on fasting metabolism 
in abdominally obese subjects
All subjects who received the low-calorie diet significantly 
lost weight (P < 0.05) (Table  1). To establish whether 
WL has any effect on the fasting levels of metabolites in 
abdominally obese subjects, Δ values were calculated per 
metabolite per subject (T0 after –T0 before). Table 3 shows 
the three metabolites that were different before and after 
the WL intervention in abdominally obese subjects in the 
fasted state. We also assessed the connection between WL 
and ratios between acetylcarnitine  (C2) and longer chain  (Cn) 
acylcarnitines. These  (C2/Cn) acylcarnitine ratios have previ-
ously been suggested as read-outs for lipid β-oxidation and 
indeed significantly correlated with HOMA (Supplementary 
Material, Table S3). Although these correlations suggest that 
acylcarnitine ratios partly reflect insulin resistance, we could 
not find any significant effect of WL on these acylcarni-
tine ratios, whereas we did observe an improvement in the 
HOMA index (Joris et al. 2016).
We next determined the effect of WL on gene expres-
sion in PBMCs in the fasted state. WL changed the expres-
sion of 835 genes in the abdominally obese subjects (T0 
after WL vs. T0 before WL, Fig. S2). GSEA identified 
a number of differently enriched (FDR < 0.04) pathways, 
including respiratory electron transport, and oxidative 
phosphorylation, which were negatively enriched after 
Table 2  Significant (P < 0.05, 
lFDR < 0.2) differences 
between fasting metabolite 
concentrations (FC) and 
postprandial mixed meal 
response (iAUC) in plasma 
between lean and abdominally 
obese subjects
Differences in response were calculated on the basis of iAUC 
FC fold change, iAUC incremental area under the curve
P(fasting) FC (abdominally obese T0/
lean T0)
P(iAUC)
Acylcarnitines
 Palmitoylcarnitine < 0.01 1.25
Amino acids and related metabolites
 Serine < 0.01 0.86
 Beta alanine 0.02 1.07
 Asparagine 0.02 0.9
 Creatinine < 0.01 1.21
 Isoleucine < 0.01 1.24
 Alanine < 0.01 1.18 < 0.01
 Tyrosine < 0.01 1.2
 Valine 0.01 1.13
 Keto-leucine 0.01 1.13
 Carnitine 0.02 1.07
 Leucine 0.03 1.11
 Proline < 0.01
 Methylmalonic acid < 0.01
 Threonine 0.01
 Histidine 0.01
 Methionine 0.01
 Phosphocholine 0.01
 2-Hydroxyisovalerate 0.01
Oxylipins
 5-HETE < 0.01 0.61
 12–13-EpOME 0.01 0.65
 9-HODE 0.02 0.71
 9-HOTrE 0.02 0.68
TCA cycle and related metabolites
 Glyceric acid < 0.01 0.95
 Beta glucose 0.02 1.09
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WL in abdominally obese subjects. Gene sets related to 
immune regulation and insulin signalling were positively 
enriched after WL (Supplementary Table S4). After WL, 
genes in oxidative phosphorylation and to a lesser extent 
in carbohydrate metabolism showed expression levels that 
were closer to expression levels in lean subjects (Fig. 3).
3.3  Impact of weight loss on postprandial 
metabolic response in abdominally obese 
subjects
The WL intervention had a subtle effect on the postprandial 
metabolic response in plasma, of which several examples 
Fig. 2  Postprandial mixed meal response curves of glucose, acetoac-
etate, valine and palmitoylcarnitine as representative metabolites 
from glycolysis, ketogenesis, amino acid metabolism and lipolysis, 
respectively. Mean curves are presented for lean and abdominally 
obese subjects, the latter before and after weight loss intervention 
(see Fig.  1). The bars represent variation within these groups. The 
metabolite levels for glucose and acetoacetate are presented as abso-
lute concentrations, for valine and palmitoylcarnitine relative concen-
trations are presented
 P. Fazelzadeh et al.
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are presented in Fig. 2. For 11 metabolites the postprandial 
response as expressed as iAUC was significantly different 
before and after WL intervention. For a major part these 
metabolites consisted of oxylipins derived from enzymatic 
oxidation of arachidonic acid (Table 3). We also observed 
shifts in the response to the mixed-meal challenge after the 
control intervention (Supplementary Table S5).
To identify differences in PBMC gene expression in 
response to the mixed-meal challenge before and after WL, 
differences were calculated as ∆ values in both groups 
(T4–T0, D2 vs. T4–T0, D1). We identified 384 genes 
that showed a different postprandial response after the 
WL intervention as compared to the response before WL. 
Furthermore, we identified 226 genes that showed a dif-
ferent postprandial response after the control intervention 
(Fig. S2). GSEA showed that oxidative phosphorylation and 
the electron transport chain were the main affected path-
ways. Before the intervention oxidative phosphorylation and 
the electron transport chain were downregulated upon the 
mixed-meal challenge, whereas after the WL intervention 
oxidative phosphorylation and the electron transport chain 
were upregulated (Fig. 3). In contrast, gene sets related to the 
immune system and carbohydrate metabolism showed the 
opposite pattern with down-regulation upon a mixed-meal 
challenge before the intervention and a dampened response 
or even up-regulation upon a mixed-meal challenge after the 
intervention (Fig. 3; Supplementary Table S6).
In short, GSEA showed that at fasting, 161 gene sets 
were upregulated and 120 gene sets were down regulated 
(FDR < 0.2) in the WL abdominally obese group (Supple-
mentary Table S4), while in the abdominally obese control 
group 219 gene sets were upregulated and 3 gene sets were 
downregulated (data not shown). GSEA showed that upon 
mixed meal challenge, 6 gene sets were upregulated and 95 
gene sets were down regulated (FDR < 0.2) in WL abdomi-
nally obese group (Supplementary Table S6), while in CTRL 
abdominally obese group only 45 gene sets were downregu-
lated (data not shown).
4  Discussion
In this study, we examined whether a standardized mixed-
meal challenge could reveal a WL-induced shift from the 
abdominally obese phenotype towards a lean one. We were 
particularly interested in finding out whether measurement 
of the response to a dietary challenge would reveal addi-
tional changes in metabolic phenotype compared to meas-
urements in the fasting state.
4.1  Metabolic differences between lean 
and abdominally obese
The observed differences in the fasting levels of BCAAs 
reflect differences in metabolic homeostasis between lean 
and abdominally obese and are in line with previous obser-
vations (Newgard et al. 2009). This indicates that the study 
was adequately powered to detect metabolic differences at 
baseline. The shift in fasting levels of these metabolites 
can be explained by their positive correlation with insulin 
resistance, which was significantly different for the lean and 
abdominally obese subjects (Newgard et al. 2009; Newgard 
2012). We could however not confirm previously observed 
differences in metabolites related to the TCA cycle between 
the abdominally obese and lean subjects (Newgard et al. 
2009). For a range of oxylipins significantly lower fasting 
plasma levels were observed in abdominally obese subjects 
relative to the lean group, which we attribute to a decrease 
in enzymatic lipid oxidation. Recently, ratios between  C2/Cn 
acylcarnitines were brought forward as putative read-outs for 
β-oxidation rate (Krug et al. 2012). Although these ratios 
correlated with HOMA (Supplementary Table S3), we could 
not find a difference of  C2/Cn acylcarnitine ratios between 
the lean and abdominally obese groups, even though insulin 
sensitivity differed between the two groups. This suggests 
that while these ratios are correlated with insulin sensitiv-
ity, they do not provide an increased sensitivity compared 
to classical markers.
Table 3  Effect of weight loss (P < 0.05, lFDR < 0.2) on fasted state 
(T0, FC) metabolite concentrations and postprandial mixed meal 
challenge response (iAUC) in plasma of abdominally obese subjects
Differences in postprandial response were determined on the basis of 
iAUC 
FC fold change (T0, after weight loss/T0, before weight loss), iAUC 
incremental area under the curve significant at P < 0.05
Metabolites P FC(WL) P(iAUC)
Amino acids and related metabolites
 Glycine < 0.01 1.18
 Creatinine < 0.01 0.88
 Glutamine < 0.01
 Histidine < 0.01
 Creatine < 0.01
 Pyroglutamic acid < 0.01
 Glutamic acid < 0.01 0.66
Oxylipins
 TXB2 < 0.01
 PGE2 < 0.01
 12S.HHTrE < 0.01
 5.HETE < 0.01
 11.HETE 0.02
TCA cycle and related metabolites
 Glucose 0.01
Acylcarnitines
 Choline 0.01
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The lean and abdominally obese subjects also differed 
in their postprandial mixed meal response. The individual 
variation, however, was rather large (compared to analytical 
variation), as shown in Fig. 2. An elaborate interpretation 
of the differences in response between lean and abdominally 
obese is given in the Supplementary Material. The strong 
inter-individual variation in response, the confounding of the 
metabolic response with dietary influx amino acids, and our 
conservative statistical testing criteria did not allow for inte-
grated metabolic pathway analysis due to the limited number 
of affected metabolites. We could however reproduce previ-
ously observed differences in the postprandial responses of 
amino acids between lean and abdominally obese (Badoud 
et al. 2015). We could not reproduce earlier observations 
showing differences in the postprandial responses of free 
fatty acids between lean and abdominally obese. We attrib-
uted this to dietary intake of fatty acids during the post-
prandial phase. We also did not observe differences in post-
prandial response of FAACs and hence could not confirm 
earlier observations that lean and abdominally obese differ 
in β-oxidation of fatty acids (Badoud et al. 2015). Also no 
differences in postprandial responses of BCAAs between 
lean and abdominally obese could be discerned, very likely 
also due to direct dietary intake of amino acids. We did 
however observe a striking difference for a BCAA transami-
nation product, i.e., 2-hydroxyisovalerate (P < 0.05). This 
Fig. 3  Overview of lean-abdominally obese differences in expres-
sion of genes related to (left) oxidative phosphorylation and (right) 
carbohydrate metabolism in PBMCs at fasting (T0) and during post-
prandial response (∆ lean vs. ∆ abdominally obese postprandial) to a 
mixed meal challenge. Also shown are effects of WL on gene expres-
sion in PBMCs of abdominally obese subjects at baseline (abdomi-
nally obese after WL vs. abdominally obese before WL) and during 
postprandial phase (∆ abdominally obese after WL vs. ∆ abdominally 
obese before WL). The heatmap is based on moderated t-statistics for 
each comparison, which has the same interpretation as an ordinary 
t-statistic except that the standard errors have been moderated across 
genes using a simple Bayesian model
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metabolite requires the branched chain amino transferase 
and keto acid dehydrogenase (BCKDH) complex for further 
catabolism to propionic acid. The function of the BCKDH 
complex is known to be compromised in insulin resist-
ant subjects, leading to increased fasting levels of BCAA 
(Badoud et  al. 2015). Compromised BCKDH function 
should also increase postprandial accumulation of other 
upstream metabolites such as 2-hydroxyisovalerate. This is 
indeed what was observed in the abdominally obese relative 
to lean subjects (Podebrad et al. 1999). We also observed 
difference for a range of postprandial oxylipin responses 
after a mixed meal challenge in lean and abdominally obese 
subjects. A recent study however did not show differences in 
postprandial response of oxylipins between lean and abdom-
inally obese subjects upon high fat challenges (Strassburg 
et al. 2014). This indicates that the postprandial response of 
oxylipins is not only determined by the lean-abdominally 
obese phenotype but also depends on the composition of 
the meal challenge.
Although the lean and abdominally obese showed several 
distinct differences in the postprandial metabolic response, 
these differences were less pronounced when compared to a 
previous study using an OGTT challenge (Geidenstam et al. 
2014). That study showed blunted responses of BCAAs and 
FFAs, in contrast to our study. We attribute this to dietary 
intake of these metabolites since our mixed meal challenge 
was quite rich in protein and fatty acids. This likely shrouds 
observation of differences in postprandial response due to 
phenotypical differences.
Gene sets related to oxidative phosphorylation were 
higher expressed in abdominally obese in comparison to 
lean subjects at baseline in the fasting state. This is consist-
ent with a previous study that found that dietary background 
can affect PBMC gene expression. Consumption of mono-
unsaturated fatty acids and a Mediterranean diet compared 
with a saturated fatty acid diet decreased the expression of 
genes involved in oxidative phosphorylation in abdominally 
overweight males and females (Dijk et al. 2012). Differences 
were also found in gene sets related to the immune system. 
These gene sets were lower expressed in abdominally obese 
when compared to lean subjects. However, these effects were 
relatively small, yet consistent with a previous study that 
also showed rather small differences in a number of immune 
related gene sets that showed lower expression in abdomi-
nally obese subjects when compared to lean subjects (Esser 
et al. 2015).
In contrast to the fasting state, we observed that in the 
postprandial state expression of genes related to immune 
pathways was increased in abdominally obese relative to 
lean subjects. In addition, we observed larger changes in 
expression of gene sets involved in carbohydrate metabolism 
in the abdominally obese, which could be due to differences 
in insulin sensitivity and the activity of energy metabolism 
pathways. The observed differences in PBMC gene expres-
sion between abdominally obese and lean subjects at base-
line and after the mixed meal challenge point towards a dif-
ference in haemostasis and immune function between the 
two groups.
Based on the number of genes differently expressed 
between lean and abdominally obese we can conclude that 
our mixed meal challenge was not able to magnify differ-
ences in transcriptional response in PBMC between lean and 
abdominally obese when compared to the fasting state (fast-
ing: 1862 genes and postprandial: 1537 genes). This stands 
in contrast to a study by Esser et al. demonstrating that an 
OLTT challenge with 95 g of fat high in SFA or MUFA 
increased the number of genes significantly differentially 
expressed between lean and abdominally obese subjects. 
This study also showed a higher number of changed genes 
in abdominally obese relative to lean subjects when compar-
ing the MUFA and the SFA challenges. The authors hypoth-
esised that a MUFA challenge is more potent in inducing 
transcriptional differences between lean and abdominally 
obese in PBMCs than a SFA challenge. Our mixed meal 
challenge was higher in carbohydrate and protein and lower 
in fat content. These fats were also predominantly saturated, 
which may explain the weaker gene expression response to 
our mixed meal challenge. This weaker response can also 
be explained by large variety in response induced by the 
absorption a complex mixture of nutrients.
4.2  Effect of weight loss on fasting metabolism 
in abdominally obese subjects
The effect of WL on fasting metabolism of abdominally 
obese subjects only involved two amino acids and creatinine. 
We have refrained from speculation on the underlying bio-
logical mechanism of this minor difference in fasting metab-
olism. Our observation stands in contrast to the previously 
observed changes in baseline levels of BCAAs, AAACs, 
carnitine and metabolites of the TCA cycle (Shah et al. 
2012; Wahl et al. 2015). It also contrasts with the observed 
improvement of insulin sensitivity upon WL in our study 
population, indicating that the abdominally obese phenotype 
partially reversed towards a lean one (Newgard et al. 2009; 
Newgard 2012). Furthermore, we did not observe an effect 
of WL on  C2/Cn acylcarnitine ratios.
In our study, WL affected the expression of 835 genes in 
the fasting state. WL resulted in lower expression of genes 
involved in oxidative phosphorylation PBMCs at baseline. 
These genes also show lower expression levels in lean com-
pared to abdominally obese individuals (Fig. 3). Further-
more, baseline expression of genes involved in carbohydrate 
metabolism is different between lean and abdominally obese 
subject. However, the expression levels of these genes do not 
seem to change towards the expression levels observed in 
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the lean upon WL. Moreover, gene sets involved in immune 
regulation were higher expressed after WL, while these gene 
sets were enriched in lean subjects compared to abdominally 
obese subjects before the intervention. A possible explana-
tion for the observed differences in expressions of immune-
related genes is a shift in cell population occurring during 
the study. Unfortunately, differentiated blood cell counts 
were not performed in the current study so we cannot con-
firm this. Therefore, we cannot conclude that the observed 
differences are due to a difference in immune status between 
lean and abdominally obese.
We also observed significant differences in the control 
group, which was not expected since our control group 
matched in BMI and waist circumference at the start of the 
intervention and the control group did not lose any weight. 
These differences suggest a seasonal effect; however, due 
to the design of the study this explanation is unlikely. Our 
remaining explanation is that the participants in the control 
group changed their behaviour during the course of the study 
although they were asked to maintain habitual alcohol con-
sumption and physical activity and did report any change in 
these parameters (Joris et al. 2016). Such change in behav-
iour of participants in the control group is not uncommon, 
as described in a systematic review of WL intervention trials 
(Waters et al. 2012).
4.3  Effect of weight loss on postprandial metabolic 
response in abdominally obese subjects
The predominant effect of the WL intervention on the post-
prandial response in abdominally obese subjects involved 
three amino acids, five oxylipins, choline, creatine and glu-
cose. Several differences in the postprandial response that 
were observed between lean and abdominally obese subjects, 
however, were not observed after WL in the abdominally 
obese. Lower glucose levels after WL suggests that the 
mixed meal challenge stimulates a more prolonged insulin 
response, which is in line with previous observations (Stro-
eve et al. 2015). In our study the WL intervention induced a 
small number of shifts in fasting metabolite level; the impact 
of the mixed meal on the postprandial metabolic response 
involved more metabolites but was still subtle. This is in 
line with Geidenstam et al. who also found only a modest 
number of differences in the postprandial metabolic response 
upon OGTT, mostly branched and aromatic acids, after WL 
and a maintenance period in abdominally obese subjects. 
The authors attribute this to the heterogeneity in the post-
prandial response of abdominally obese to an OGTT chal-
lenge. The heterogeneity in postprandial response to a mixed 
meal most likely also explains why also in our study only 
modest postprandial effects of WL were observed. In con-
trast, a recent study by Kardinaal et al. (2015), suggested that 
a change in challenge response is a more sensitive biomarker 
of metabolic resilience than changes in fasting metabolism. 
This discrepancy might be due to either their particular study 
population, which consisted of a homogeneous group of 
males with metabolic syndrome, whereas within our study 
the subjects were a more heterogeneous group of healthy 
abdominally obese. The study from Kardinaal et al. also 
used a high fat challenge, which may provoke a more tar-
geted postprandial response as the mixed meal used in our 
study. In our study the strong and rapid direct uptake of 
amino acids and fatty acids from the mixed meal may have 
shrouded observation of postprandial metabolic differences. 
Therefore the recent recommendation of a mixed meal as the 
optimal challenge for demonstrating subtle improvements in 
metabolic flexibility needs to be expounded with regard to 
the composition of such a challenge (Stroeve et al. 2015).
Genes related to carbohydrate metabolism were down-
regulated in abdominally obese subjects upon a mixed meal 
challenge after WL compared to before the WL interven-
tion. Figure 3 shows that the reduced response of genes 
in the carbohydrate metabolism to the challenge results in 
expression levels that are more comparable to expression 
levels observed in lean subjects. As insulin sensitivity is 
also improved after WL the attenuation of the expression of 
genes in carbohydrate metabolism seems consistent with this 
improvement in insulin sensitivity. Similarly, genes related 
to inflammatory pathways also showed a dampened response 
in the abdominally obese after WL, which is also more in 
line with the response observed in lean subjects. Overall, 
we conclude that the postprandial responses to WL seem 
to shift towards the lean response after WL with regard to 
carbohydrate metabolism and the inflammatory response. 
Although the observed shift suggests that subjects after WL 
have a leaner phenotype, they do not reach the level of lean 
subjects, which is in line with the actual WL. Furthermore, 
at the end of the study the subjects were maintaining weight. 
This may result in a less pronounced response when compar-
ing to studies in which subjects were still losing weight at 
the time of measurement.
5  Conclusion
Our results are in line with recent observations that the meta-
bolic phenotype of abdominally obese and lean subjects is 
different with respect to both the plasma metabolome and 
PBMC gene expression in the fasting state. The difference in 
phenotypic flexibility between lean and abdominally obese 
was also reflected in the mixed meal postprandial response 
of the plasma metabolome and PBMC gene expression. 
The difference in response of a downstream metabolite of 
a branched chain amino acid suggests compromised func-
tion of the BCKDH complex in the abdominally obese. The 
metabolites and genes that differ at baseline show minor 
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overlap with those that are different in their postprandial 
response. This indicates that the mechanisms accounting 
for the observed differences between lean and abdominally 
obese in the fasted state are different from the mechanisms 
underlying the differences during the postprandial mixed 
meal response.
Compared to the difference in lean-abdominally obese 
metabolic phenotype, WL had a small effect on the fast-
ing plasma metabolome. Also, the effect of WL on baseline 
gene expression in PBMCs was smaller; the main effect 
was a shift of genes related to oxidative phosphorylation 
towards the lean phenotype. The impact of WL on the 
mixed meal postprandial response of plasma metabolites 
and PBMC gene expression was modest and mainly point 
to altered enzymatic lipid oxidation and carbohydrate metab-
olism upon WL. The WL induced shifts of baseline and 
postprandial response of plasma metabolome and PBMC 
gene expression showed little overlap with the differences 
between lean-abdominally obese metabolic phenotype.
The modest number of significant differences in post-
prandial metabolic responses between lean-abdominally 
obese and abdominally obese before and after WL may be 
explained by the complex composition of the mixed meal. 
Hence, the composition of meal challenges should be con-
sidered carefully in order to provoke a distinct postprandial 
metabolic response.
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